WHAT'S NEW

"Did you know? In a human body, the dense network of blood vessels that carry blood to and from the heart is over 60,000 miles long. - 4 hours ago via Facebook
"A medical revolution is happening, and this revolution is called "angiogenesis." There's new hope; spread the word: http://t.co/3OZmpdS3JP - 7 hours ago via Twitter
"In the U.S., there are 13 approved anti-cancer therapies with recognized antiangiogenic properties in #oncology: - 1 day ago via Facebook
"Angiogenesis pioneer Dr. Judah Folkman’s legacy of bold and creative thinking endures: http://t.co/5UO8fBsJFA - 1 day ago via Twitter
"Angiogenesis is the “common denominator” in society’s most feared diseases. Spread the word: www.angio.org - 2 days ago via Facebook
"In total, more than 300 angiogenesis inhibitors have been discovered to date. Learn more: http://t.co/NMoO3aRENX - 2 days ago via Twitter
"A medical revolution is happening, and this revolution is called "angiogenesis." There's new hope; spread the word: ow.ly/BzOoF - 3 days ago via Facebook
"Did you know? Our veins contain 65% of the body's total blood supply at any given moment! - 3 days ago via Twitter
"Anti-VEGF agent aflibercept approved in Canada for diabetic macular edema (DME), a vision-impairing disease: http://t.co/4Bl4ozuRUU - 1 week ago via Twitter
Health Canada recently approved anti-VEGF agent alibercept (Eylea) for the treatment of diabetic macular edema (DME). Eylea is also approved in Canada Read More >
"More news for antiangiogenic agent aflibercept and DME patients! - 3 weeks ago via Facebook
"FDA Grants Priority Review of Antiangiogenic Agent Aflibercept for Treatment of Diabetic Retinopathy in DME Patients: http://t.co/mMGKxIk9m6 - 3 weeks ago via Twitter
The U.S. Food and Drug Administration (FDA) has accepted for priority review the supplemental biologics license application (sBLA) for EYLEA® (afli Read More >
In the National Institutes of Health (NIH) sponsored, Diabetic Retinopathy Clinical Research Network (DRCR.net) comparative effectiveness study in pat Read More >
"Anti-VEGF Agent Aflibercept is Approved in Japan for Treatment of Diabetic Macular Edema: http://t.co/o5BBq6a47i - 4 weeks ago via Twitter
"Angiogenesis is your lifeline. Find out why: http://t.co/nBxBHgkcrC - 1 month ago via Twitter
"Angiogenesis Pioneer Dr. Judah Folkman’s Legacy of Bold and Creative Thinking Endures: http://t.co/PAPBF8rsHi - 1 month ago via Twitter
"It's been a busy year! Check out our latest white papers, patient guides and infographics-- all available here: http://t.co/6OVb4A9jtp - 1 month ago via Twitter
The U.S. Food and Drug Administration (FDA) approved antiangiogenic agent bevacizumab (Avastin®) in combination with chemotherapy for the treatment o Read More >
On October 14, the Angiogenesis Foundation hosted a Patient Forum and Dinner, "Antiangiogenesis: Answer to Cancer," at the Westin Boston Waterfront Ho Read More >
The U.S. Food and Drug Administration (FDA) has approved EYLEA® (aflibercept) Injection for the treatment of Macular Edema following Retinal Vein Occ Read More >
Bayer HealthCare's Japanese subsidiary, Bayer Yakuhin, Ltd. has received approval from the Japanese Ministry of Health, Labour and Welfare (MHLW) for Read More >
The U.S. Food and Drug Administration, on August 14, 2014 approved bevacizumab solution for intravenous infusion (Avastin®, Genentech, Inc.) for the Read More >
Aflibercept (EYLEA) Injection has been approved by the European Commission for the treatment of visual impairment due to Diabetic Macular Edema (DME). Read More >
The U.S. Food and Drug Administration (FDA) has approved aflibercept (EYLEA®) Injection for the treatment of Diabetic Macular Edema (DME). The recom Read More >
The U.S. Food and Drug Administration (FDA) has accepted a supplemental Biologics License Application (sBLA) from Genentech and granted Priority Revie Read More >

ANGIO LIFE

Dr. Li shares 22 Cancer Fighting Tips with Dr. Oz

Dr. William Li joins Dr. Oz to share 22 ways to cut your risk of cancer risk by 50 percent. Read More >

Dr. William Li presents at TED

Dr. William Li presents “Can we eat to starve cancer?” at TED 2010 in Long Beach, CA. Read More >

 

IN THE MEDIA

4744.Reuters-Logo

November 6, 2014: For the second consecutive year, the Angiogenesis Foundation has received the highest rating from Charity Navigator, the prominent independent evaluator of charities. Read More >

DoctorOZ-1

May 20, 2014: “The Dr. Oz Show” features Dr. William Li who shares 3 all-natural breakthroughs that can reduce your risk of cancer. Read More >

marketwatch-logo

April 23, 2014: The Bates-Jensen Wound Reach Foundation and the Angiogenesis Foundation announce Keith Brantly will run in the Wound Reach Foundation OUCH! Race. Read More >

DoctorOZ (1)

February 7, 2014: Dr. William Li appears on “The Dr. Oz Show” to share 22 ways to cut your cancer risk by 50%. Read More >

yahoo-news-logo

January 21, 2014: The Angiogenesis Foundation, in collaboration with musician / activist Peter Gabriel, has launched the Do iT Yourself Health Revolution Read More >

yahoo-news-logo

November 7, 2013: The Angiogenesis Foundation receives highest rating from Charity Navigator, a premiere charity evaluator, for good governance, fiscal management, accountability and transparency. Read More >

marketwatch-logo

September 26, 2013: The Angiogenesis Foundation Launches Multimedia Campaigns for Saving Vision at the 13th Euretina Congress Read More >

bostoncomlogo

September 26, 2013: The Angiogenesis Foundation Releases International White Paper on Improving Outcomes in the Treatment and Management of Metastatic Colorectal Cancer at the European Cancer Congress 2013 Read More >

marketwatch-logo

September 26, 2013: The Angiogenesis Foundation Releases International White Paper on Advancing Treatment of Wet Age-Related Macular Degeneration at the 13th Euretina Congress Read More >

WSJ-Logo2

July 16, 2013: The Angiogenesis Foundation Presents Concept of Antiangiogenic Foods at IFT 2013 Annual Meeting + Food Expo Read More >

usatoday_logo

June 4, 2013: Dr. William Li discusses the impact of drug shortages for cancer patients in USA Today. Read More >

usatoday_logo

June 3, 2013: Dr. William Li discusses recent developments for patients with metastatic thyroid cancer in USA Today. Read More >

WSJ-Logo2

May 31, 2013: The Angiogenesis Foundation releases Advancing Critical Pathways Forward in the Treatment of Colorectal and Kidney Cancer – White Papers at the ASCO Annual Meeting 2013. Read More >

WSJ-Logo2

May 30, 2013: The Angiogenesis Foundation Launches Science of Colorectal Cancer Patient Resource at ASCO Annual Meeting 2013. Read More >

WSJ-Logo2

May 7, 2013: The Angiogenesis Foundation releases white paper, “Critical Pathways Forward for Wet Age-Related Macular Degeneration in Asia Pacific.” Read More >

HEAR FROM THE EXPERTS

   

The “Best of Antiangiogenesis” is a series of webcasts, generated through Project ENABLE™, featuring presentations from leading medical experts describing research and perspectives on new angiogenesis-based therapies.

To view additional webcasts, click here
 

LEARN ABOUT DISEASE TREATMENTS

PUBLICATIONS

GREEN TEA

Our tea research is part of our Eat to Beat Cancer initiative, which is setting out to find foods and beverages that restore balance to the body's angiogenesis system. By purchasing this tea you are supporting our research and helping to advance the frontiers of cancer prevention.